Glenmark Pharmaceuticals Limited
NSE: GLENMARKINE935A01035·HealthcareMidcap 150·www.glenmarkpharma.com ↗·Mcap ₹69,769 Cr·Listed 2000
₹2,380.00▼ ₹50.40  (−2.07%)
52W: ₹1,793 – ₹2,538 · Vol: 7.9L shares · Close 25 Sept
Set Alert

Quarterly results

No results filings parsed for GLENMARK yet. Filings load from NSE's XBRL results; check back after the next refresh.

Annual results

financial years ending March · from the fourth-quarter filings
No annual results on record.
Key ratios
P/E (TTM)–
P/B–
ROE–
Net margin–
Debt / equity–
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)–
Market cap–
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.